Literature DB >> 11337540

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

K Ishii1, F Willoch, S Minoshima, A Drzezga, E P Ficaro, D J Cross, D E Kuhl, M Schwaiger.   

Abstract

UNLABELLED: Despite the increased use of statistical mapping to detect brain functional changes in Alzheimer's disease (AD), potential artifacts introduced by stereotactic anatomic standardization of atrophied brains have not been examined carefully. We investigated the effects of anatomic standardization by Statistical Parametric Mapping (SPM) and NEUROSTAT.
METHODS: First, 10 AD patients and 10 age-matched healthy volunteers underwent 18F-FDG brain PET imaging. Each image set was standardized to a stereotactic brain template using SPM or NEUROSTAT, followed by pixel normalization to the global or cerebellar activity. Within-group comparisons of standardized image sets by each method and a between-group comparison of healthy volunteers and AD patients were performed using the statistical analysis routines of SPM. Second, simulated PET image sets were generated from segmented MR image sets of 5 healthy volunteers and 5 AD patients. Using the anatomic standardization parameters estimated on the simulated image sets, original gray matter MR image sets were transformed to the stereotactic coordinate system. Between-group subtraction analyses of the transformed gray matter image sets between healthy volunteers and AD groups were performed to examine the accuracy of cortical gray matter matching.
RESULTS: Between-group comparison by SPM or NEUROSTAT showed generally similar areas of hypometabolism in bilateral temporoparietal, posterior cingulate, and left frontal cortices. Both methods showed possible deformation artifacts in the anterior part of the corpus callosum. The localization of the peak hypometabolism varied considerably between the two methods when global normalization was applied. The use of a common brain template for standardization resulted in asymmetric differences in cortical margins, indicating systematic differences in the deformation algorithms. The realistic simulation study revealed gray matter mismatches to be 20% greater with SPM than with NEUROSTAT.
CONCLUSION: Although different statistical mapping methods may yield grossly similar patterns of hypometabolism in AD, the extent, severity, and peak location of metabolic changes can be inconsistent. Deformation accuracy appears to be more prone to atrophy. These limitations need to be considered carefully in the application and interpretation of brain mapping analysis in atrophied brains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337540

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  40 in total

1.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

2.  Effects of aging on regional cerebral blood flow assessed by using technetium Tc 99m hexamethylpropyleneamine oxime single-photon emission tomography with 3D stereotactic surface projection analysis.

Authors:  Kazuo Takahashi; Shuhei Yamaguchi; Shotai Kobayashi; Yasushi Yamamoto
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.

Authors:  Kazunari Ishii; Satoshi Minoshima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Frontal diaschisis in a German case of fatal familial insomnia.

Authors:  Marc Wermke; Stijan Teipel; Thomas Fuchsberger; Hans Kretzschmar; Ingo Westner; Mira Schröder; Harald Hampel; Alex Drzezga
Journal:  J Neurol       Date:  2006-10-13       Impact factor: 4.849

5.  Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease.

Authors:  Sönke Arlt; Stefanie Brassen; Holger Jahn; Florian Wilke; Martin Eichenlaub; Ivayla Apostolova; Fabian Wenzel; Frank Thiele; Stewart Young; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-14       Impact factor: 9.236

6.  Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose.

Authors:  Setsu Sakamoto; Kazunari Ishii; Kayo Hosaka; Tetsuya Mori; Masahiro Sasaki; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

7.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

8.  Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT.

Authors:  Kayo Hosaka; Kazunari Ishii; Setsu Sakamoto; Norihiro Sadato; Hiroshi Fukuda; Takashi Kato; Kazuro Sugimura; Michio Senda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-21       Impact factor: 9.236

9.  Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.

Authors:  Lisa Mosconi; Wai H Tsui; Karl Herholz; Alberto Pupi; Alexander Drzezga; Giovanni Lucignani; Eric M Reiman; Vjera Holthoff; Elke Kalbe; Sandro Sorbi; Janine Diehl-Schmid; Robert Perneczky; Francesca Clerici; Richard Caselli; Bettina Beuthien-Baumann; Alexander Kurz; Satoshi Minoshima; Mony J de Leon
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

10.  Diagnosis of regional cerebral blood flow abnormalities using spect: agreement between individualized statistical parametric maps and visual inspection by nuclear medicine physicians with different levels of expertise in nuclear neurology.

Authors:  Euclides Timóteo da Rocha; Carlos Alberto Buchpiguel; Ricardo Nitrini; Sergio Tazima; Stela Verzinhase Peres; Geraldo Busatto Filho
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.